Dominant encephalopathy mimicking mitochondrial disease
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
The hallmark of acute necrotizing encephalopathy (ANE) is multiple, symmetric brain lesions.1 ANE is triggered by a viral infection in previously healthy children. The presenting symptoms are coma, convulsions, vomiting, hyperpyrexia, and hepatomegaly. Recently a dominant mutation (c.1880C→T, p.Thr585Met) in the gene encoding the nuclear pore protein Ran Binding Protein 2 (RANBP2) has been reported in familial, recurrent ANE (ANE1).2 In isolated ANE the typical brain lesions are located in the thalami bilaterally, putamina, deep periventricular white matter, cerebellum, and brainstem,3,4 while in ANE1 the MRI changes are seen in the external capsules, claustrum, limbic structure, or temporal lobes.2 Hepatic involvement is common in Asian patients with ANE, but not in ANE1.2 Differential diagnosis of ANE includes mitochondrial disorders, especially Leigh/Alpers syndrome,5 inflammatory, demyelinating brain diseases, acute disseminating encephalomyelitis (ADEM), or even multiple sclerosis (MS).6
We report the clinical, MRI, and molecular genetic findings of ANE in a 3-generation family, and discuss the differential diagnosis.
Patients.
We included 6 patients with ANE in 3 generations (figure, G). ANE was recurrent in patients 2 and 5. Five of the episodes appeared in infancy, …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Costs and Utilization of New-to-Market Neurologic Medications
Dr. Robert J. Fox and Dr. Mandy Leonard
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Articles
Autosomal dominant acute necrotizing encephalopathyD. E. Neilson, R. M. Eiben, S. Waniewski et al.Neurology, July 21, 2003 -
Article
Differential diagnosis and evaluation in pediatric inflammatory demyelinating disordersKevin Rostasy, Barbara Bajer-Kornek, Sunita Venkateswaran et al.Neurology, August 29, 2016 -
Article
Cathepsin A–related arteriopathy with strokes and leukoencephalopathy (CARASAL)Marianna Bugiani, Sietske H. Kevelam, Hannah S. Bakels et al.Neurology, September 24, 2016 -
Articles
MRS in presymptomatic MAPT mutation carriersA potential biomarker for tau-mediated pathologyK. Kantarci, B.F. Boeve, Z.K. Wszolek et al.Neurology, August 30, 2010